Literature DB >> 29214601

Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.

Hima Bindu Ruttala1, Thiruganesh Ramasamy1,2, Thiagarajan Madeshwaran3, Tran Tuan Hiep1, Umadevi Kandasamy4, Kyung Taek Oh5, Han-Gon Choi6, Chul Soon Yong7, Jong Oh Kim8.   

Abstract

The development of novel drug delivery systems based on well-defined polymer therapeutics has led to significant improvements in the treatment of multiple disorders. Advances in material chemistry, nanotechnology, and nanomedicine have revolutionized the practices of drug delivery. Stimulus-responsive material-based nanosized drug delivery systems have remarkable properties that allow them to circumvent biological barriers and achieve targeted intracellular drug delivery. Specifically, the development of novel nanocarrier-based therapeutics is the need of the hour in managing complex diseases. In this review, we have briefly described the fundamentals of drug targeting to diseased tissues, physiological barriers in the human body, and the mechanisms/modes of drug-loaded carrier systems. To that end, this review serves as a comprehensive overview of the recent developments in stimulus-responsive drug delivery systems, with focus on their potential applications and impact on the future of drug delivery.

Entities:  

Keywords:  Drug delivery systems; Nanomedicine; Polymer therapeutics; Stimulus-responsive

Mesh:

Substances:

Year:  2017        PMID: 29214601     DOI: 10.1007/s12272-017-0995-x

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  9 in total

1.  In vitro analysis of microRNA-26a in chronic lymphocytic leukemia cells.

Authors:  Jing Li; Chang-Kui Sun
Journal:  Int J Mol Med       Date:  2018-10-10       Impact factor: 4.101

2.  Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation.

Authors:  Thi-Thao-Linh Nguyen; Van-An Duong; Han-Joo Maeng; Sang-Cheol Chi
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

3.  A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.

Authors:  Di Zhang; Qian Xu; Ning Wang; Yanting Yang; Jiaqi Liu; Guohua Yu; Xin Yang; Hui Xu; Hongbo Wang
Journal:  Int J Nanomedicine       Date:  2018-08-10

4.  3D-Printed Gastroretentive Sustained Release Drug Delivery System by Applying Design of Experiment Approach.

Authors:  Hyeon Myeong Jeong; Kwon-Yeon Weon; Beom Soo Shin; Soyoung Shin
Journal:  Molecules       Date:  2020-05-16       Impact factor: 4.411

5.  Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells.

Authors:  Zar Chi Soe; Jun Bum Kwon; Raj Kumar Thapa; Wenquan Ou; Hanh Thuy Nguyen; Milan Gautam; Kyung Taek Oh; Han-Gon Choi; Sae Kwang Ku; Chul Soon Yong; Jong Oh Kim
Journal:  Pharmaceutics       Date:  2019-02-01       Impact factor: 6.321

6.  The AIB1siRNA-loaded hyaluronic acid-assembled PEI/heparin/Ca2+ nanocomplex as a novel therapeutic strategy in lung cancer treatment.

Authors:  Ying Hao; Yongsheng Gao; Yedan Wu; Changshan An
Journal:  Int J Mol Med       Date:  2018-12-03       Impact factor: 4.101

7.  Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells.

Authors:  Zar Chi Soe; Bijay Kumar Poudel; Hanh Thuy Nguyen; Raj Kumar Thapa; Wenquan Ou; Milan Gautam; Kishwor Poudel; Sung Giu Jin; Jee-Heon Jeong; Sae Kwang Ku; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Asian J Pharm Sci       Date:  2018-10-20       Impact factor: 6.598

Review 8.  Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.

Authors:  Reju George Thomas; Suchithra Poilil Surendran; Yong Yeon Jeong
Journal:  Front Mol Biosci       Date:  2020-12-18

Review 9.  Recent advances of drug delivery nanocarriers in osteosarcoma treatment.

Authors:  Shang-Yu Wang; Hong-Zhi Hu; Xiang-Cheng Qing; Zhi-Cai Zhang; Zeng-Wu Shao
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.